Table 4. 30-days and 1-year follow up after successful sealing by CS implantation (n = 99).
| 30 days follow up | 1 year follow up | |
|---|---|---|
| Acute ST, n (%) | 4 (4.0) | 4 (4.0) |
| Subacute ST, n (%) | 1 (1.0) | 1 (1.0) |
| Late ST, n (%) | - | 1 (1.0) |
| TVR, (%) | 8 (8.1) | 15 (15.2) |
| TLR, (%) | 8 (8.1) | 13 (13.1) |
| Cardiac death, (%) | 6 (6.1) | 7 (7.1) |
| MI, (%) | 6 (6.1) | 11 (11.0) |
| MACE, (%) | 15 (15.1) | 26 (26.2) |
ST- sent thrombosis; TVR- target vessel revascularization; TLR- target lesion revascularization, CV- cardiovascular, MI- myocardial infarction, MACE: major adverse cardiac events.